ArticleLeukemia2025
The BIM deletion polymorphism potentiates the survival of leukemia stem and progenitor cells and impairs response to targeted therapies.
Mengge Yu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it